Literature DB >> 12678854

Protein Therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery.

Hideki Matsui1, Kazuhito Tomizawa, Yun-Fei Lu, Masayuki Matsushita.   

Abstract

Protein Therapy is a newly developed method, which allows proteins, peptides and biologically active compounds to penetrate across the plasma membrane of eukaryotic cells by a polyarginine (most efficiently by 11-arginine, 11R) protein transduction domain. This method enables us to control the localization of targeted substances in subcellular compartments, such as the nuclei, mitochondria and post-synaptic density. The method is very efficient and applicable not only to cultured cells but also to tissue slices and the whole animal. Brain, heart, skeletal muscle, liver, pancreas and lymphocytes are efficient target organs and tissues for Protein Therapy. The method is therefore a very useful strategy in the post-genomic era. In this mini-review, the development of Protein Therapy and its application for cancer cells and neuroscience study will be shown.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678854     DOI: 10.2174/1389203033487270

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  13 in total

1.  A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model.

Authors:  Emily L Que; Elizabeth J New; Christopher J Chang
Journal:  Chem Sci       Date:  2012-04-18       Impact factor: 9.825

2.  Protein therapy using heme-oxygenase-1 fused to a polyarginine transduction domain attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.

Authors:  Tomoyuki Ogawa; Daniel Hänggi; Yumei Wu; Hiroyuki Michiue; Kazuhito Tomizawa; Shigeki Ono; Hideki Matsui; Isao Date; Hans-Jakob Steiger
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-08       Impact factor: 6.200

3.  Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53.

Authors:  Sachiko Yamada; Hiroshi Kanno; Nobutaka Kawahara
Journal:  J Neurooncol       Date:  2012-04-18       Impact factor: 4.130

4.  Advances in Systemic siRNA Delivery.

Authors:  Qixin Leng; Martin C Woodle; Patrick Y Lu; A James Mixson
Journal:  Drugs Future       Date:  2009-09       Impact factor: 0.148

5.  Complexation of a poly-L-arginine with low molecular weight heparin enhances pulmonary absorption of the drug.

Authors:  Amit Rawat; Tianzhi Yang; Alamdar Hussain; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2007-10-23       Impact factor: 4.200

6.  Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549.

Authors:  Wei Zhang; Jing Zhu; Jing Bai; Hui Jiang; Fangli Liu; An Liu; Peng Liu; Guohua Ji; Rongwei Guan; Donglin Sun; Wei Ji; Yang Yu; Yan Jin; Xiangning Meng; Songbin Fu
Journal:  J Exp Clin Cancer Res       Date:  2010-06-17

7.  Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors.

Authors:  Taku Kaitsuka; Hirofumi Noguchi; Nobuaki Shiraki; Takuya Kubo; Fan-Yan Wei; Farzana Hakim; Shoen Kume; Kazuhito Tomizawa
Journal:  Stem Cells Transl Med       Date:  2013-11-29       Impact factor: 6.940

8.  Differential intracellular distribution of DNA complexed with polyethylenimine (PEI) and PEI-polyarginine PTD influences exogenous gene expression within live COS-7 cells.

Authors:  Stephen R Doyle; Chee Kai Chan
Journal:  Genet Vaccines Ther       Date:  2007-11-26

9.  Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.

Authors:  Suresh Ramakrishna; Abu-Bonsrah Kwaku Dad; Jagadish Beloor; Ramu Gopalappa; Sang-Kyung Lee; Hyongbum Kim
Journal:  Genome Res       Date:  2014-04-02       Impact factor: 9.043

Review 10.  Proteins reprogramming: present and future.

Authors:  Yang Yang; Bin Liu; Jianwen Dong; Liangming Zhang; Mao Pang; Limin Rong
Journal:  ScientificWorldJournal       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.